The mighty mice prove pluripotency for iPSCs
|
Novel proteasome inhibitors as potential drugs to combat tuberculosis
|
Purinergic control of neutrophil activation
|
Synthetic genomes for synthetic biology
|
Polyglutamine diseases: Where does toxicity come from? What is toxicity? Where are we going?
|
Comparative analysis of REGγ expression in mouse and human tissues
|
Sphingosine-1-phosphate mediates proliferation maintaining the multipotency of human adult bone marrow and adipose tissue-derived stem cells
|
RNA interference reveals a requirement for both p18INK4c and p27Kip1 in B lymphopoiesis
|
IL-15Rα-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation
|
Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation
|